Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Dr. Anzueto

Contact

210-617-5256

anzueto@uthscsa.edu

Departments & Divisions

Antonio Anzueto, M.D.

Professor

Dr. Antonio Anzueto is a Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the University of Texas Health San Antonio and specializes in Pulmonary Medicine/ Critical Care. He completed His undergraduate studies at Colegio Liceo Javier  in 1972. He received his Doctor of Medicine in 1979 at the University of San Carlos, in Guatemala City. In 1989, he completed her internship and residency in internal medical followed by Pulmonary Medicine/ Critical Fellowship at University of Texas, Health, San Antonio. He is an active member of the American Thoracic Society, American Collegue of Chest Physicians (CHEST),  European Respiratory Society, Latin American Thoracic Society (ALAT), Global Obstruction Lung Disease (GOLD).

  • Professional Background

    Education

    • 1991 - Postdoctoral Fellowship - Critical Care Medicine - University of Texas Health Science Center at San Antonio
    • 1990 - Postdoctoral Fellowship - Pulmonary Diseases - University of Texas Health Science Center at San Antonio
    • 1988 - Residency - Internal Medicine - University of Texas Health Science Center at San Antonio
    • 1987 - Internship - Internal Medicine - University of Texas Health Science Center at San Antonio
    • 1981 - Residency - Internal Medicine - Hospital General San Juan de Dios
    • 1979 - MD - Medicine - Universidad de San Carlos de Guatemala
    • 1979 - Internship - Internal Medicine - Hospital General San Juan de Dios
    • 1972 - BS - Colegio Liceo Javier

    Appointments

    • 9/2004 - Professor - University of Texas Health Science Center at San Antonio, Medicine, San Antonio
    • 1/2000 - Chief, Pulmonary Section - The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 9/1996 - Medical Director, Pulmonary Function Laboratory - The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 1/1995 - Medical Director, Respiratory Therapy Department - The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 1/1995 - Director Pulmonary Function Lab - University Hospital, Medicine, San Antonio
    • 1/1995 - Medical Director Bronchoscopy Laboratory - The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 1/1995 - Director, Pulmonary Function Laboratory - The South Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 7/1992 - Director Pulmonary Service Spinal Cord Unit - The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 7/1992 - Staff Physician - University Hospital, Medicine, San Antonio
    • 7/1992 - Staff Physician - The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, Medicine, San Antonio
    • 10/1983 - Adjunct Scientist - Southwest Foundation for Biomedical Research, Medicine, San Antonio

  • Instruction & Training

    • 7/2001 - Present, General Supervision and Attending of Pulmonary and Critical Care Fellows, UTHSCSA/VA/UHS

  • Research & Grants

    Grants

    Federal

    Funding Agency NIH Title Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Status Active Period 9/2007 - Present Role Co-Investigator Grant Detail Genetic Epidemiology of Chronic Obstructive Pulmonary Disease. The original local grant was approximately $1.2 million.
    Renewal - 7/1/2017-7/31/2018 Funding Agency   Title The MENDS II Study: Maximizing the Efficacy of sedation and reducing neurological dysfunction and mortality in septic patients with acute respiratory failure. Status Complete Period 7/2012 - 6/2017 Role Co-Investigator Grant Detail This mutlicenter, randomized, controlled trial will be evaluating the efficacy and safety of sedation as well as reducing neurological dysfunction and mortality in septic patients with acute respiratory failure.

    Private

    Funding Agency Pharmaceutical - Eli Lilly Title Safety and Efficacy of Drotecogin Alpha (activated) in septic shock Status Active Period - Present Role Co-Investigator Grant Detail  

     

    Funding Agency   Title Analysis of Factors Associated to Mortality of Reintubated Patients Within 48 Hours After Scheduled Extubation: Observational, Prospective, Multicenter Study Status Complete Period - Present Role Co-Investigator Grant Detail   Funding Agency   Title Efficacy of Macrolide Immunomodulation in Severe Sepsis Status Active Period - Present Role Co-Investigator Grant Detail  

  • Publications

      Abstract

      Oscar Pe?uelas, Alfonso Muriel, Victor Abraira, Fernando Frutos-Vivar, Jordi Mancebo, Konstantinos Raymondos, Bin Du, Arnaud W. Thille, Fernando Rios, Marco Gonzalez, Lorenzo del-Sorbo, Niall D. Ferguson, Maria del Carmen Marin, Bruno Valle Pinheiro, Marco Antonio Soares, Nicolas Nin, Salvatore M. Maggiore, Andrew Bersten, Pravin Amin, Nahit Cakar, Gee Young Suh, Fekri Abroug, Manuel Jibaja, Dimitros Matamis, Amine Ali Zeggwagh, Yuda Sutherasan, Anzueto AR, Andres Esteban. Inter-country variability over time in the mortality of mechanically ventilated patients; 2020 Jan. (Intensive Care Medicine). Wernly B, Frutos-Vivar F, Pe?uelas O, Raymondos K, Muriel A, Du B, Thille AW, Rios F, Gonzalez M, Del-Sorbo L, Del Carmen Marin M, Pinheiro BV, Soares MA, Nin N, Maggiore SM, Bersten A, Kelm M, Amin P, Cakar N, Lichtenauer M, Suh GY, Abroug F, Jibaja M, Matamis D, Zeggwagh AA, Sutherasan Y, Anzueto AR, Esteban A, Jung C. Easy prognostic assessment of concomitant organ failure in critically ill patients undergoing mechanical ventilation. In European Journal of Internal Medicine; 2019 Dec. (Eur J Intern Med). Zachary Boivin, Mario F. Perez, Nkiruka C, Atuegwu, Mark Metersky, Carlos A. Alvarez, Anzueto AR, Eric M. Mortensen. Association of atypical antipsychotics and mortality for patients hospitalized with pneumonia; 2019 Nov. (ERS; vol. 5). Aliberti S, Cook GS, Babu BL, Reyes LF,, H Rodriguez A, Sanz F, Soni NJ, Anzueto AR, Faverio P, Sadud RF, Muhammad I, Prat C, Vendrell E, Neves J, Kaimakamis E, Feneley A, Swarnakar R, Franzetti F, Carugati M, Morosi M, Monge E, Restrepo MI, GLIMP investigators. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia; 2019 Oct. (Journal Infect). Gary D. Owen, Joanna L. Stollings, Shayan Rakhit, Li Wang, Chang Yu, Morgan A. Hosay, James W. Stewart, Fernando Frutos-Vivar, Oscar Pe?uelas, Andres Esteban, Anzueto AR, Konstantinos Raymondos, Fernando Rios, Arnaud W. Thille, Marco Gonzalez, Bin Du, Salvatore M. Maggiore, Dimitrios Matamis, Fekri Abroug, Pravin Amin, Amine Ali Zeggwagh, Mayur B. Patel. International Analgesia, Sedation, and Delirium Practices: a prospective cohort study; 2019 Jul. (Journal of Intensive Care). Yii ACA, Loh CH, Tiew PY, Xu H, Taha AAM, Koh J, Tan J, Lapperre TS, Anzueto AR, Tee AKH. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits"; 2019 Mar. (International Journal Of Chronic Obstructive Pulmonary Disease). Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto AR, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Victorina Lopez Varela M, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung: Epub; 2017 Mar. (Arch Bronconeumol). Calverley PM, Ericksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fageras M. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD; 2016 Dec. (Int J Chron Obstruct Pulmon Dis). Susanto IS, Sako EY, Anzueto AR, Levine SM, Peters JI, Cronin T, Jenkinson SG, Bryan C. Outcome of single lung transplants from the same donor: "Pulmonary Twinning"; 1995 Oct. (Chest; vol. 108, no. 3).

      Journal Article

      John R. Hurst, Neil Skolnik, Gerald J. Hansen, Anzueto AR, Gavin C. Donaldson, Mark T. Dransfield, Precil Varghese. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life European Journal of Internal Medicine 2019 Sep;. Maleki-Yazdi MR, Singh D, Anzueto AR, Tombs L, Fahy WA, Naya I. Assessing Short-term Deterioration in Maintenance-naive Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials Adv Ther 2019 Jan;33(12):2188-2199. Rodriguez A, Ferri C, Martin - Loeches I, Diaz E, Masclans JR, Gordo F, Sole_violan J, Bodi M, Aviles-Jurado FX, Trefler S, Magret M, Moreno G, Reyes LF, Marin-Corral J, Yevene JC, Esteban A, Anzueto AR, Restrepo MI. Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection Respir Care 2017 Oct;62(10):1307-1315. Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Anzueto AR, Babu BL, Gonzalez-Juarbe N, Rodriguez AH, Jimenez A, Chalmers JD, Aliberti S, Sibila O, Winter VT, Coalson JJ, Giavedoni LD, Dela Cruz CS, Waterer GW, Witzenrath M, Suttorp N,, Dube PH,, Orihuela CJ. Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling Am J Respir Crit Care Med 2017 Sep;196(5):609-620. Mangat M, Amalakuhan B, Habib S, Reyes LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer GW, Martin-Loeches I, Blanquer J, Sanz F, Marcos PJ, Sole-Violan J, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orihuela CJ,, Restrepo MI. High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis Eur Respir J 2017 Jul;50(1). Kim V, Zhao H, Boriek AM, Anzueto AR, Soler X, Bhatt SP, Rennard SI, Wise R, Comellas A, Ramsdell JW, Kinney GL, Han MK, Martinez CH, Yen A, Black-Shinn J, Porszasz J, Criner GJ, Hanania NA, Sharafkhaneh A, Crapo JD, Make BJ,, Silverman EK, Curtis JL. ersistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease Am Thorac Soc 2017 Jul;13(7). Busch R, Hobbs BD, Zhou J, Castaldi PJ, McGeachie MJ, Hardin ME, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Agusti A, Make BJ, Crapo JD, Calverley PM, Donner CF, Lomas DA, Wouters EF, Vestbo J, Tal-Singer R, Bakke P, Gulsvik A, Litonjua AA, Sparrow D, Pare PD, Levy RD, Rennard SI, Beaty TH, Hokanson J, Silverman EK, Cho MH, National Emphysema Treatment Trial Genetics, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-Points, International COPD Genetics Network, COPDGene Investigators. Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects Am J Respir Cell Mol Biol 2017 Jul;35(36). Kerkhof M, Sonnappa S, Postma DS, Brusselle G, Agusti A,, Anzueto A, Jones R, Papi A, Pavord I, Pizzichini E, Popov T, Roche N, Ryan D, Thomas M, Vogelmeier C, Chisholm A, Freeman D, Bafadhel M, Hillyer EV, Price DB. Blood eosinophil count and exacerbation risk in patients with COPD Eur Respir J 2017 Jul;:20-54. Miravitlles M, Anzueto AR. Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics? Int J Mol Sci 2017 Jul;18(7). Miravitlles M, Anzueto AR, Jardim JR. Optimizing bronchodilation in the prevention of COPD exacerbations Respir Res 2017 Jun;1(125). Eriksson G, Calverley PM, Jenkins CR, Anzueto AR, Make BJ, Lindberg M, Fager?s M, Postma DS. The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials Int J Chron Obstruct Pulmon Dis 2017 May;1457-(1468). Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R. The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD Int J Chron Obstruct Pulmon Dis 2017 May;1325(1337). Anzueto AR, Miravitlles M. Pathophysiology of dyspnea in COPD Postgrad Med 2017 Apr;366(374). Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto AR, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Respirology 2017 Apr;575(601). Nambiar AM, Anzueto AR, Peters JI. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis PloS ONE 2017 Apr;12(4). Tejerina E, Pelosi P, Muriel A, Pe?uelas O, Sutherasan Y, Frutos-Vivar F, Nin N, Davies AR, Rios F, Violi DA, Raymondos K, Hurtado J, Gonzalez M, Du B, Amin P, Maggiore SM,, Thille AW, Soares MA, Jibaja M, Villagomez AJ, Kuiper MA, Koh Y, Moreno RP, Zeggwagh AA, Matamis D, Anzueto AR, Ferguson ND, Esteban A. Association between ventilatory settings and development of acute respiratory distress syndrome in mechanically ventilated patients due to brain injury VENTILA group 2017 Apr;:341-345. Wedzicha JA Ers Co-Chair, Miravitlles M,, Hurst JR, Calverley PM, Albert RK, Anzueto AR, Criner GJ,, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC,, Krishnan JA Ats Co-Chair. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline Eur Respir J 2017 Mar;49(3). Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto AR, Barnes PJ, Bourbeau J, Celli BR, Chen R,, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Arch Bronconeumol 2017 Mar;53(3):128-149. Rodrigo GJ, Price D, Anzueto AR, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis Int J Chron Obstruct Pulmon Dis 2017 Mar;907(922). Nin N, Muriel A, Penuelas O, Brochard L, Lorente JA, Ferguson ND, Raymondos K, Rios F, Violi DA, Thrille AW, Gonzalez M, Villagomez AJ, Hurtado J, Davies AR, Du B, Maggiore SM, Soto L, D`Empaire G, Matamis D, Abroug F, Moreno RP, Soares MA, Arabi Y, Sandi F, Jibaja M, Amin P, Koh Y, Kuiper MA, Bulow HH, Zeggwagh AA, Anzueto AR, Sznajder F, Esteban A. Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome Intensive Care Med 2017 Feb;:200-208. Dransfield MT, Kunisaki KM, Strand MJ, Anzueto AR, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease Am J Respir Crit Care Med 2017 Feb;195(3):324-330. Miravitlles M, Anzueto AR. A new two-step algorithm for the treatment of COPD Eur Respir J 2017 Feb;49(2). Amalakuhan B, Habib SA, Mangat M, Reyes LF, Rodriguez AH, Hinojosa CA, Soni NJ, Gilley RP, Bustamante CA, Anzueto AR, Levine SM, Peters JI, Aliberti S, Sibila O, Chalmers JD, Torres A, Waterer GW, Martin-Loeches, Bordon J, Blanquer J, Sanz F, Marcos PJ, Rello J, Ramirez J, Sole-Violan, Luna CM, Feldman C, Witzenrath M, Wunderink RG, Stolz D, Wiemken TL, Shindo Y, Dela Cruz CS, Orihuela CJ, Restrepo MI. Endothelial Adhesion Molecules and Multiple Organ Failure in Patients With Severe Sepsis Cytokine 2016 Dec;88:267-273. Attridge RT, Frei CR, Pugh MJ, Lawson KA, Ryan L, Anzueto AR, Metersky ML, Restrepo MI, Mortensen EM. Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes J Crit Care 2016 Dec;:265-271. Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fager?s M, Postma DS. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD Int J Chron Obstruct Pulmon Dis 2016 Dec;37(6):897-904. Attridge RT, Frei CR, Pugh MJ, Lawson KA, Ryan L, Anzueto AR, Metersky ML, Restrepo MI, Mortensen EM. Health Care-associated pneumonia in the intensive care unit:Guideline-concordant antibiotics and outcomes J Crit Care 2016 Dec;36(1):265-271. Restrepo MI, Reyes LF, Anzueto AR. Complication of Community-Acquired Pneumonia (Including Cardiac Complications) Semin Respir Crit Care Med 2016 Dec;37(6):897-904. Reyes LF, Restrepo MI, Hinojosa CA, Soni N, Shenoy AT, Gilley RP, Gonzalez-Juarbe N, Noda JR, Winter VT, de la Garza MA, Shade RE, Coalson JJ, Giavedoni LD, Anzueto AR, Orihuela CJ. A Non-Human Primate Model of Severe Pneumococcal Pneumonia PLoS One 2016 Nov;. Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Shenoy AT, Gilley RP, Gonzalez-Juarbe N, Noda JR, Winter VT, de la Garza MA, Shade RE, Coalson JJ, Giavedoni LD, Anzueto A, Orihuela CJ. A Non-Human Primate Model of Severe Pneumococcal Pneumonia PLoS One 2016 Nov;17(11). Zhong N, Moon HS, Lee KH, Mahayiddin AA, Boonsawat W, Isidro MG, Bai C, Mueller A, Metzdorf N, Anzueto AR. TIOtropium Safety and Performance In Respimat? (TIOSPIRTM ): Analysis of Asian cohort of COPD patients Respirology 2016 Nov;21(8):1397-1403. Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto AR, Alagappan VK, Siddiqui S, Rekeda L, Miller CJ, Zetterstrand S, Reisner C, Rennard SI. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND) Am J Respir Crit Care Med 2016 Sep;:559-567. Pavord ID, Lettis S, Anzueto AR, Barnes N. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis Lancet Respir Med 2016 Sep;:731-741. Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto AR, Zhu H. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design Int J Chron Obstruct Pulmon Dis 2016 Aug;. Wise R, Anzueto AR, Dahl R, Dusser D, Calverley P. Tiotropium safety in `real-world` populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology Br J Clin Pharmacol 2016 Aug;. Bhatt SP, Soler X, Wang X, Murray S, Anzueto AR, Beaty TH, Boriek AM, Casaburi R, Criner GJ, Diaz AA, Dransfield MT, Curran-Everett D, Galban CJ, Hoffman EA, Hogg JC, Kazerooni EA, Kim V, Kinney GL, Lagstein A, Lynch DA, Make BJ, Martinez FJ, Ramsdell JW, Reddy R, Ross BD, Rossiter HB, Steiner RM, Strand MJ, Van Beek EJ, Wan ES, Washko GR, Wells JM, Wendt CH, Wise RA, Silverman EK, Crapo JD, Bowler RP, Han MK. Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease Am J Respir Crit Care Med 2016 Jul;194(2):178-184. Halpin DM, Vogelmeier C, Pieper MP, Metzdorf N, Richard F, Anzueto AR. Effect of tiotropium on COPD exacerbations: A systematic review Respir Med 2016 May;. Pe?uelas O, Muriel A, Frutos-Vivar F, Fan E, Raymondos K, Rios F, Nin N, Thille AW, Gonzalez M, Villagomez AJ, Davies AR, Du B, Maggiore SM, Matamis D, Abroug F, Moreno RP, Kuiper MA, Anzueto AR, Ferguson ND, Esteban A. Prediction and Outcome of Intensive Care Unit-Acquired Paresis J Intensive Care Med 2016 Apr;. Calverley PM, Postma DS, Anzueto AR, Make BJ, Eriksson G, Peterson S, Jenkins CR. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations Int J Chron Obstruct Pulmon Dis 2016 Feb;:381-390. Dusser D, Wise RA, Dahl R, Anzueto AR, Carter K, Fowler A, Calverley PM. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(?) trial Int J Chron Obstruct Pulmon Dis 2016 Jan;20(11):133-145. Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, Johnson CS, Alvarez CA, Frei CR, Good C, Restrepo MI, Downs JR, Anzueto AR. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia JAMA 2014 Jun;311(21):2199-2208. Maselli DJ, Anzueto A. The need to further understand who gets hospitalized for a COPD exacerbation Multidisciplinary Respiratory Research 2012 Jun;7(1):7-7. Maselli DJ, Fernandez J, Whong CY, Echevarria K, Nambiar AM, Anzueto AR, Restrepo MI. Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia Infect Drug Resist 2012 Feb;5:43-51. Adams SG, Anzueto A, Briggs DD, Leimer I, Kesten S. Evaluation of withdrawal of maintenance tiotropium in COPD Respir Med 2009 Oct;103(10):1415-1420. Adams SG, Anzueto AR. A pharmacotherapeutic approach to improving health-related quality of life for patients with chronic obstructive pulmonary disease Clin Pulm Med 2009 May;16(3):115-126. Adams SG, Smith PK, Allan PF, Anzueto AR, Pugh JA, Cornell JE. Systematic review of the Chronic Care Model in chronic obstructive pulmonary disease prevention and management Arch Intern Med 2007 Mar;167:551-561. Adams SG, Anzueto AR. Antibiotic therapy in acute exacerbation of chronic bronchitis: The antibiotics. Part 2 Pulmonary Perspectives 2002 Jan;19:1-5. Adams SG, Anzueto A, Anzueto AR. Antibiotic therapy in acute exacerbations of chronic bronchitis Semin Respir Infect 2000 Sep;15(3):234-247.

      Not Specified

      Kazuto Matsunaga, Keiji Oishi, Marc Miravitlles, Anzueto AR. Time To Revise COPD Treatment Algorithm International Journal of Chronic Obstructive Pulmonary Disease 2019 Sep;:2229-2234. Lombardi R, Nin N, Nin N, Pe?uelas O, Ferreiro A, Rios F, Marin MC, Raymondos K, Lorente JA, Koh Y,, Hurtado J, Gonzalez M, Abroug F, Jibaja M, Arabi Y, Arabi Y, Matamis D, Anzueto AR, Esteban A. Acute Kidney Injury in Mechanically Ventilated Patients: The Risk Factor Profile Depends on the Timing of Aki Onset VENTILA Group 2017 Apr;. Anzueto AR. Complication of Community-Acquired pneumonia(including cardiac complications) Respir Crit Care Med 2016 Dec;. Anzueto AR. Assessing short-term deterioration in Maintenance-naive patients with COPD reveiving umeclidinium J Crti Care 2016 Dec;. Anzueto AR. Association between ventilatory settings and development of acute respiratory distress syndrome in mechanicaly ventilated patients due to brain injury J Crit Care 2016 Nov;.